{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:40:01Z","timestamp":1772750401243,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2003,3,1]]},"DOI":"10.1038\/sj.leu.2402843","type":"journal-article","created":{"date-parts":[[2003,3,28]],"date-time":"2003-03-28T15:24:54Z","timestamp":1048865094000},"page":"568-575","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Fibrates and medroxyprogesterone acetate induce apoptosis of primary Burkitt's lymphoma cells and cell lines: potential for applying old drugs to a new disease"],"prefix":"10.1038","volume":"17","author":[{"given":"S L","family":"Fenton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q T","family":"Luong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Sarafeim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K J W","family":"Mustard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Pound","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J C","family":"Desmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M T","family":"Drayson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C M","family":"Bunce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,3,19]]},"reference":[{"key":"BF2402843_CR1","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/0277-5379(91)90397-V","volume":"27","author":"E Bouffet","year":"1991","unstructured":"Bouffet E, Frappaz D, Pinkerton R, Favrot M, Philip T . Burkitt's lymphoma: a model for clinical oncology. Eur J Cancer 1991; 27: 504\u2013509.","journal-title":"Eur J Cancer"},{"key":"BF2402843_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0165-5876(86)80060-X","volume":"12","author":"DB Kearns","year":"1986","unstructured":"Kearns DB, Smith RJH, Pitcock JK . Burkitt's lymphoma. Int J Pediatr Otorhinolaryngol 1986; 12: 73\u201384.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"BF2402843_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1056\/NEJM197707142970202","volume":"297","author":"JL Ziegler","year":"1977","unstructured":"Ziegler JL . Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience. N Engl J Med 1977; 297: 75\u201380.","journal-title":"N Engl J Med"},{"key":"BF2402843_CR4","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1056\/NEJM199605093341906","volume":"334","author":"JT Sandlund","year":"1996","unstructured":"Sandlund JT, Downing JR, Crist WM . Non-Hodgkin's lymphoma in children. N Engl J Med 1996; 334: 1238\u20131248.","journal-title":"N Engl J Med"},{"key":"BF2402843_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S1368-8375(97)00041-9","volume":"34","author":"J Shapira","year":"1998","unstructured":"Shapira J, Peylan-Ramu N . Burkitt's lymphoma. Oral Oncol 1998; 34: 15\u201323.","journal-title":"Oral Oncol"},{"key":"BF2402843_CR6","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1046\/j.1365-2141.2001.02654.x","volume":"112","author":"M Bower","year":"2001","unstructured":"Bower M . Acquired immunodeficiency syndrome-related systemic non-Hodgkin's lymphoma. Br J Haematol 2001; 112: 863\u2013873.","journal-title":"Br J Haematol"},{"key":"BF2402843_CR7","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0950-3536(96)80026-6","volume":"9","author":"DJ Straus","year":"1996","unstructured":"Straus DJ . Treatment of Hodgkin's disease: the role of radio- and\/or chemotherapy in advanced stages. Baillieres Clin Haematol 1996; 9: 553\u2013558.","journal-title":"Baillieres Clin Haematol"},{"key":"BF2402843_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/BF02740674","volume":"10","author":"HM Sucov","year":"1995","unstructured":"Sucov HM, Evans RM . Retinoic acid and retinoic acid receptors in development. Mol Neurobiol 1995; 10: 169\u2013184.","journal-title":"Mol Neurobiol"},{"key":"BF2402843_CR9","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/S0171-2985(11)80227-5","volume":"188","author":"L Faulkner","year":"1993","unstructured":"Faulkner L, Katz DR, Brickell PM . Retinoic acid induces changes in c-fgr proto-oncogene mRNA levels in Burkitt's lymphoma cells. Immunobiology 1993; 188: 460\u2013468.","journal-title":"Immunobiology"},{"key":"BF2402843_CR10","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1182\/blood.V96.2.711.014k02_711_718","volume":"96","author":"M Quaia","year":"2000","unstructured":"Quaia M, Zancai P, Cariati R, Rizzo S, Boiocchi M, Dolcetti R . Glucocorticoids promote the proliferation and antagonize the retinoic acid-mediated growth suppression of Epstein\u2013Barr virus-immortalized B lymphocytes. Blood 2000; 96: 711\u2013718.","journal-title":"Blood"},{"key":"BF2402843_CR11","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1038\/sj.onc.1202089","volume":"17","author":"P Zancai","year":"1998","unstructured":"Zancai P, Cariati R, Rizzo S, Boiocchi M, Dolcetti R . Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event. Oncogene 1998; 17: 1827\u20131836.","journal-title":"Oncogene"},{"key":"BF2402843_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/(SICI)1097-0215(20000501)86:3<375::AID-IJC12>3.0.CO;2-Z","volume":"86","author":"R Cariati","year":"2000","unstructured":"Cariati R, Zancai P, Quaia M, Cutrona G, Giannini F, Rizzo S et al. Retinoic acid induces persistent, RARalpha-mediated anti-proliferative responses in Epstein\u2013Barr virus-immortalized b lymphoblasts carrying an activated C-MYC oncogene but not in Burkitt's lymphoma cell lines. Int J Cancer 2000; 86: 375\u2013384.","journal-title":"Int J Cancer"},{"key":"BF2402843_CR13","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.1365-2141.1999.01355.x","volume":"105","author":"SL Fenton","year":"1999","unstructured":"Fenton SL, Drayson MT, Hewison M, Vickers E, Brown G, Bunce CM . Clofibric acid: a potential therapeutic agent in AML and MDS. Br J Haematol 1999; 105: 448\u2013451.","journal-title":"Br J Haematol"},{"key":"BF2402843_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0167-4889(96)00005-5","volume":"1311","author":"CM Bunce","year":"1996","unstructured":"Bunce CM, Mountford JC, French PJ, Mole DJ, Durham J, Michell RH, et al. Potentiation of myeloid differentiation by anti-inflammatory agents, by steroids and by retinoic acid involves a single intracellular target, probably an enzyme of the aldoketoreductase family. Biochim Biophys Acta 1996; 1311: 189\u2013198.","journal-title":"Biochim Biophys Acta"},{"key":"BF2402843_CR15","first-page":"373","volume":"13","author":"H Wang","year":"1996","unstructured":"Wang H, Grand RJ, Milner AE, Armitage RJ, Gordon J, Gregory CD . Repression of apoptosis in human B-lymphoma cells by CD40-ligand and Bcl-2: relationship to the cell-cycle and role of the retinoblastoma protein. Oncogene 1996; 13: 373\u2013379.","journal-title":"Oncogene"},{"key":"BF2402843_CR16","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/sj.cdd.4400710","volume":"7","author":"J Gordon","year":"2000","unstructured":"Gordon J, Challa A, Levens JM, Gregory CD, Williams JM, Armitage RJ et al. CD40 ligand, Bcl-2, and Bcl-xL spare group I Burkitt lymphoma cells from CD77-directed killing via Verotoxin-1 B chain but fail to protect against the holotoxin. Cell Death Differ 2000; 7: 785\u2013794.","journal-title":"Cell Death Differ"},{"key":"BF2402843_CR17","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1182\/blood.V99.7.2545","volume":"99","author":"A Serafeim","year":"2002","unstructured":"Serafeim A, Grafton G, Chamba A, Gregory CD, Blakely RD, Bowery NG et al. 5-Hydroxytryptamine drives apoptosis in biopsylike Burkitt lymphoma cells: reversal by selective serotonin reuptake inhibitors. Blood 2002; 99: 2545\u20132553.","journal-title":"Blood"},{"key":"BF2402843_CR18","first-page":"754","volume":"25","author":"GJ Schuurhuis","year":"1997","unstructured":"Schuurhuis GJ, Oberink JW, Bontje PM, Broxterman HJ . The PGP specific combination Syto\u00ae16\/PSC833 detects early apoptosis in CD34 positive progenitor cells. Exp Haematol 1997; 25: 754\u2013759.","journal-title":"Exp Haematol"},{"key":"BF2402843_CR19","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1002\/1097-0142(19851201)56:11<2576::AID-CNCR2820561107>3.0.CO;2-I","volume":"56","author":"M Izuo","year":"1985","unstructured":"Izuo M, Yoshida M, Tominaga T, Abe O, Enomoto K, Nomura Y et al. A phase III trial of oral high-dose medroxyprogesterone acetate (MPA) versus mepitiostane in advanced postmenopausal breast cancer. Cancer 1985; 56: 2576\u20132579.","journal-title":"Cancer"},{"key":"BF2402843_CR20","doi-asserted-by":"crossref","unstructured":"A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators. Br Heart J 1978; 40: 1069\u20131118.","DOI":"10.1136\/hrt.40.10.1069"},{"key":"BF2402843_CR21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0360-3016(01)01451-1","volume":"50","author":"EM Bessell","year":"2001","unstructured":"Bessell EM, Graus F, Lopez-Guillermo A, Villa S, Verger E, Petit J et al. CHOD\/BVAM regimen plus radiotherapy in patients with primary CNS non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 2001; 50: 457\u2013464.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF2402843_CR22","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1200\/JCO.2001.19.9.2390","volume":"19","author":"NL Kobrinsky","year":"2001","unstructured":"Kobrinsky NL, Sposto R, Shah NR, Anderson JR, DeLaat C, Morse M et al. Outcomes of treatment of children and adolescents with recurrent non-Hodgkin's lymphoma and Hodgkin's disease with dexamethasone, etoposide, cisplatin, cytarabine, and L-asparaginase, maintenance chemotherapy, and transplantation: Children's Cancer Group Study CCG-5912. J Clin Oncol 2001; 19: 2390\u20132396.","journal-title":"J Clin Oncol"},{"key":"BF2402843_CR23","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S0360-3016(97)89486-2","volume":"38","author":"BW Corn","year":"1997","unstructured":"Corn BW, Donahue BR, Rosenstock JG, Cooper JS, Xie Y, Brandon AH et al. Palliation of AIDS-related primary lymphoma of the brain: observations from a multi-institutional database. Int J Radiat Oncol Biol Phys 1997; 38: 601\u2013605.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF2402843_CR24","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1056\/NEJM199911113412007","volume":"341","author":"R Kuppers","year":"1999","unstructured":"Kuppers R, Klein U, Hansmann ML, Rajewsky K . Cellular origin of human B-cell lymphomas. N Engl J Med 1999; 341: 1520\u20131529.","journal-title":"N Engl J Med"},{"key":"BF2402843_CR25","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1002\/eji.1830211209","volume":"21","author":"YJ Liu","year":"1991","unstructured":"Liu YJ, Zhang J, Lane PJ, Chan EY, MacLennan IC . Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur J Immunol 1991; 21: 2951\u20132962.","journal-title":"Eur J Immunol"},{"key":"BF2402843_CR26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/eji.1830220138","volume":"22","author":"K Hollowood","year":"1992","unstructured":"Hollowood K, Macartney J . Cell kinetics of the germinal center reaction \u2013 a stathmokinetic study. Eur J Immunol 1992; 22: 261\u2013266.","journal-title":"Eur J Immunol"},{"key":"BF2402843_CR27","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1002\/eji.1830250719","volume":"25","author":"JR Goodlad","year":"1995","unstructured":"Goodlad JR, Macartney JC . Germinal-center cell proliferation in response to T-independent antigens: a stathmokinetic, morphometric and immunohistochemical study in vivo. Eur J Immunol 1995; 25: 1918\u20131926.","journal-title":"Eur J Immunol"},{"key":"BF2402843_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/(SICI)1096-9896(199807)185:3<229::AID-PATH86>3.0.CO;2-L","volume":"185","author":"K Hollowood","year":"1998","unstructured":"Hollowood K, Goodlad JR . Germinal centre cell kinetics. J Pathol 1998; 185: 229\u2013233.","journal-title":"J Pathol"},{"key":"BF2402843_CR29","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1161\/01.CIR.98.19.2088","volume":"98","author":"B Staels","year":"1998","unstructured":"Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart JC . Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 1998; 98: 2088\u20132093.","journal-title":"Circulation"},{"key":"BF2402843_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/00041433-199904000-00009","volume":"10","author":"I Pineda Torra","year":"1999","unstructured":"Pineda Torra I, Gervois P, Staels B . Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging. Curr Opin Lipidol 1999; 10: 151\u2013159.","journal-title":"Curr Opin Lipidol"},{"key":"BF2402843_CR31","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/sj.cdd.4400551","volume":"6","author":"R Scatena","year":"1999","unstructured":"Scatena R, Nocca G, Sole PD, Rumi C, Puggioni P, Remiddi F et al. Bezafibrate as differentiating factor of human myeloid leukemia cells. Cell Death Differ 1999; 6: 781\u20136787.","journal-title":"Cell Death Differ"},{"key":"BF2402843_CR32","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1074\/jbc.M106908200","volume":"277","author":"DC Jones","year":"2002","unstructured":"Jones DC, Ding X, Daynes RA . Nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) is expressed in resting murine lymphocytes. The PPARalpha in T and B lymphocytes is both transactivation and transrepression competent. J Biol Chem 2002; 277: 6838\u20136845.","journal-title":"J Biol Chem"},{"key":"BF2402843_CR33","first-page":"505","volume":"63","author":"JC Desmond","year":"2003","unstructured":"Desmond JC, Mountford JC, Drayson MT, Walker EA, Hewison M, Ride JP, et al. The Aldo-Keto Reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs. Cancer Res 2003; 63: 505\u2013512.","journal-title":"Cancer Res"},{"key":"BF2402843_CR34","doi-asserted-by":"publisher","first-page":"6941","DOI":"10.4049\/jimmunol.165.12.6941","volume":"165","author":"J Padilla","year":"2000","unstructured":"Padilla J, Kaur K, Cao HJ, Smith TJ, Phipps RP . Peroxisome proliferator activator receptor-gamma agonists and 15-deoxy-delta(12,14)(12,14)-PGJ(2) induce apoptosis in normal and malignant B-lineage cells. J Immunol 2000; 165: 6941\u20136948.","journal-title":"J Immunol"},{"key":"BF2402843_CR35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1749-6632.2000.tb06542.x","volume":"905","author":"J Padilla","year":"2000","unstructured":"Padilla J, Kaur K, Harris SG, Phipps RP . PPAR-gamma-mediated regulation of normal and malignant B lineage cells. Ann NY Acad Sci 2000; 905: 97\u2013109.","journal-title":"Ann NY Acad Sci"},{"key":"BF2402843_CR36","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1749-6632.2000.tb06571.x","volume":"905","author":"J Padilla","year":"2000","unstructured":"Padilla J, Kaur K, Phipps RP . Effects of 15-deoxy-delta 12,14-PGJ2 on B lineage cells. Ann NY Acad Sci 2000; 905: 322\u2013325.","journal-title":"Ann NY Acad Sci"},{"key":"BF2402843_CR37","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/oxfordjournals.jbchem.a022211","volume":"124","author":"K Matsuura","year":"1998","unstructured":"Matsuura K, Shiraishi H, Hara A, Sato K, Deyashiki Y, Ninomiya M et al. Identification of a principal mRNA species for human 3alpha-hydroxysteroid dehydrogenase isoform (AKR1C3) that exhibits high prostaglandin D2 11-ketoreductase activity. J Biochem 1998; 124: 940\u2013946.","journal-title":"J Biochem"},{"key":"BF2402843_CR38","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/0006-2952(83)90474-4","volume":"32","author":"K Kontula","year":"1983","unstructured":"Kontula K, Paavonen T, Luukkainen T, Andersson LC . Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid like effects on in vitro functions of human mononuclear leukocytes. Biochem Pharmacol 1983; 32: 1511\u20131518.","journal-title":"Biochem Pharmacol"},{"key":"BF2402843_CR39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0039-128X(95)00216-D","volume":"61","author":"PJ Selman","year":"1996","unstructured":"Selman PJ, Wolfswinkel J, Mol JA . Binding specificity of medroxyprogesterone acetate and proligestone for the progesterone and glucocorticoid receptor in the dog. Steroids 1996; 61: 133\u2013137.","journal-title":"Steroids"},{"key":"BF2402843_CR40","first-page":"4055","volume":"84","author":"CM Bamberger","year":"1999","unstructured":"Bamberger CM, Else T, Bamberger AM, Beil FU, Schulte HM . Dissociative glucocorticoid activity of medroxyprogesterone acetate in normal human lymphocytes. J Clin Endocrinol Metab 1999; 84: 4055\u20134061.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF2402843_CR41","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1046\/j.1365-2141.1997.232666.x","volume":"97","author":"J Tomeczkowski","year":"1997","unstructured":"Tomeczkowski J, zur Stadt U, Reiter A, Welte K, Sykora KW . Absence of IL-6 receptor expression in fresh childhood Burkitt's lymphoma cells and induction of IL-6 receptors by Epstein\u2013Barr virus in vitro. Br J Haematol 1997; 97: 400\u2013408.","journal-title":"Br J Haematol"},{"key":"BF2402843_CR42","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1002\/1521-4141(200007)30:7<2065::AID-IMMU2065>3.0.CO;2-W","volume":"30","author":"S Mauray","year":"2000","unstructured":"Mauray S, Fuzzati-Armentero MT, Trouillet P, Ruegg M, Nicoloso G, Hart M et al. Epstein\u2013Barr virus-dependent lymphoproliferative disease: critical role of IL-6. Eur J Immunol 2000; 30: 2065\u20132073.","journal-title":"Eur J Immunol"},{"key":"BF2402843_CR43","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/sj.leu.2401371","volume":"13","author":"HG Drexler","year":"1999","unstructured":"Drexler HG, Meyer C, Gaidano G, Carbone A . Constitutive cytokine production by primary effusion (body cavity-based) lymphoma-derived cell lines. Leukemia 1999; 13: 634\u2013640.","journal-title":"Leukemia"},{"key":"BF2402843_CR44","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1182\/blood.V80.2.498.498","volume":"80","author":"D Emilie","year":"1992","unstructured":"Emilie D, Coumbaras J, Raphael M, Devergne O, Delecluse HJ, Gisselbrecht C et al. Interleukin-6 production in high-grade B lymphomas: correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus-seronegative patients. Blood 1992; 80: 498\u2013504.","journal-title":"Blood"},{"key":"BF2402843_CR45","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1006\/clim.1999.4760","volume":"92","author":"EC Breen","year":"1999","unstructured":"Breen EC, van der Meijden M, Cumberland W, Kishimoto T, Detels R, Martinez-Maza O . The development of AIDS-associated Burkitt's\/small noncleaved cell lymphoma is preceded by elevated serum levels of interleukin 6. Clin Immunol 1999; 92: 293\u2013299.","journal-title":"Clin Immunol"},{"key":"BF2402843_CR46","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1006\/viro.1998.9441","volume":"252","author":"KG Krauer","year":"1996","unstructured":"Krauer KG, Belzer DK, Liaskou D, Buck M, Cross S, Honjo T et al. Regulation of interleukin-1beta transcription by Epstein\u2013Barr virus involves a number of latent proteins via their interaction with RBP. Virology 1996; 252: 418\u2013430.","journal-title":"Virology"},{"key":"BF2402843_CR47","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.4049\/jimmunol.157.9.3949","volume":"157","author":"T Tatsuta","year":"1996","unstructured":"Tatsuta T, Cheng J, Mountz JD . Intracellular IL-1beta is an inhibitor of Fas-mediated apoptosis. J Immunol 1996; 157: 3949\u20133957.","journal-title":"J Immunol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2402843.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402843","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402843.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T14:11:36Z","timestamp":1704809496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2402843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,1]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3,1]]}},"alternative-id":["BF2402843"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2402843","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3,1]]},"assertion":[{"value":"14 August 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}